ABL Europe

From development to market ABL Europe provides GMP viral vectors, contributing to the success of our clients’ immunotherapy innovations.

ABL Europe SAS is a pure-play GMP CDMO licensed in accordance with EMA, completely dedicated to the provision of viral vector GMP contract manufacturing services, under the corporate ownership of Institut Mérieux. ABL has a strong technical & regulatory track record in process development, scale-up & GMP manufacturing of filterable & non-sterile filterable (aseptic processing) viral vectors used in all phases of clinical development globally. 2 GMP sites provide adherent platforms (< 60 m2) and suspension (< 500 L) capabilities for drug substance, with drug product (< 10,000 vials per batch) in-house, experience in process characterisation and validation, ABL provides its clients with a long-term strategic manufacturing option through clinical development & licensure for a range of viral vector gene therapy & vaccine products. ABL Europe’s clients are located worldwide.

Is this your Organization?   Request Access

Locations


France
ABL EUROPE - Strasbourg Facility
4 rue Laurent Fries
Illkirch-Graffenstaden,   67400
France, Europe

GMP Experience
A 20 year track record in the manufacture of oncolytic & gene therapy viral vectors. Drug substance (adherent & suspension) and drug product) manufacturing. Strong in-house QC testing capabilities.
France
ABL EUROPE - Lyon Facility
317, avenue Jean Jaurès,
Lyon,   69007
France, Europe

GMP Experience
A 6,500 m2 modern facility, mirroring viral vector capabilities across ABL's manufacturing sites. 3 x 200 L SUB suites, including adherent < 35 m2.

Contacts


James HARRIS
Business Development
Patrick MAHIEUX
General Manager

Production Lines

ABL EUROPE - Strasbourg Facility   Adherent GMP Facility (Grade B)
Location: Illkirch-Graffenstaden, France
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  Cell CultureCell Culture
BioReactor Scale:  100L-2000L200L Bioreactor
GMP Level:  CommercialCommercial
Biosafety Level:  Biosafety Level 3Biosafety Level 3
Single Use:  AllAll
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is AvailableCell Banking
Cell Line Development is AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is AvailableViral Manufacturing
Availability: Contact CMO

Last Update: 25JUN19

Send Inquiry about this Production Line
ABL EUROPE - Strasbourg Facility   200 L / 500 L SUB GMP Facility (Grade C)
Location: Illkirch-Graffenstaden, France
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  Cell CultureCell Culture
BioReactor Process:  BatchBatch
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Process:  PerfusionPerfusion
BioReactor Scale:  100L-2000L500L Bioreactor
GMP Level:  CommercialCommercial
Biosafety Level:  Biosafety Level 3Biosafety Level 3
Single Use:  AllAll
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is AvailableCell Banking
Cell Line Development is AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is AvailableViral Manufacturing
Availability: Available

Last Update: 25JUN19

Send Inquiry about this Production Line
ABL EUROPE - Strasbourg Facility   GMP Drug Product Aseptic Filling (Grade A / C)
Location: Illkirch-Graffenstaden, France
Main Details
Specialization:  Drug Product (Fill/Finish)Drug Product (Fill/Finish)
Dosage Form:  LiquidLiquid
Batch Size:  5,000-20,0005,000-20,000
Supported Vial Size:  2 ml2 ml
GMP Level:  CommercialCommercial
Biosafety Level:  Biosafety Level 3Biosafety Level 3
Additional Services
Analytical Services are AvailableAnalytical Services
Formulation Development is Not AvailableFormulation Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Stability Studies are AvailableStability Studies
Prefilled Syringes are Not AvailablePrefilled Syringes
Viral Manufacturing is AvailableViral Manufacturing
Availability: Available

Last Update: 25JUN19

Send Inquiry about this Production Line
ABL EUROPE - Strasbourg Facility   Process transfer, development & characterisation
Location: Illkirch-Graffenstaden, France
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  Cell CultureCell Culture
BioReactor Process:  BatchBatch
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Process:  PerfusionPerfusion
BioReactor Scale:  100L-2000L500L Bioreactor
GMP Level:  CommercialCommercial
Biosafety Level:  Biosafety Level 3Biosafety Level 3
Single Use:  AllAll
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is AvailableCell Banking
Cell Line Development is AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is AvailableViral Manufacturing
Availability: Available

Last Update: 25JUN19

Send Inquiry about this Production Line
ABL EUROPE - Lyon Facility   3 x 200 L SUB GMP Drug Substance Suites
Location: Lyon, France
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  Cell CultureCell Culture
BioReactor Process:  BatchBatch
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Process:  PerfusionPerfusion
BioReactor Scale:  100L-2000L200L Bioreactor
GMP Level:  CommercialCommercial
Biosafety Level:  Biosafety Level 2Biosafety Level 2
Single Use:  AllAll
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is AvailableCell Banking
Cell Line Development is AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is AvailableViral Manufacturing
Availability: Available

Last Update: 25JUN19

Send Inquiry about this Production Line
ABL EUROPE - Lyon Facility   Process transfer, development & characterisation
Location: Lyon, France
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  Cell CultureCell Culture
BioReactor Process:  BatchBatch
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Process:  PerfusionPerfusion
BioReactor Scale:  100L-2000L200L Bioreactor
GMP Level:  CommercialCommercial
Biosafety Level:  Biosafety Level 2Biosafety Level 2
Single Use:  AllAll
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is AvailableCell Banking
Cell Line Development is AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is AvailableViral Manufacturing
Availability: Available

Last Update: 25JUN19

Send Inquiry about this Production Line

Copyright © Kymanox, All Rights Reserved.